Totally implantable central venous access ports for longterm chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. - Biffi,R.; de Brand,F.; Orsi,F.; Pozzi,S.; Mauri,S.; Godhirsch,A.; Nole,F.; Andreoni,B. (Ann Oncol, 1998)